STAT

DECEMBER 28, 2023

Health insurance giant UnitedHealth Group used secret rules to restrict access to rehabilitation care requested by specific groups of seriously ill patients, including those who lived in nursing homes or suffered from cognitive impairment, according to internal documents obtained by STAT. The documents, which outline parameters for the clinicians who initially review referrals for rehab care, reveal that many patients enrolled in Medicare Advantage plans were routed for a quick denial based on c

Nursing Homes 145

Nursing Homes Documentation Insurance 145

The Checkup by Singlecare

DECEMBER 28, 2023

Over the past year, it’s been nearly impossible to miss the various news stories and social chatter surrounding Ozempic (semaglutide) and its revolutionary ability to help people lose weight. Ozempic is a brand name for the prescription drug semaglutide, which was originally developed for Type 2 diabetes management. Although Ozempic has been approved by the Food and Drug Administration (FDA) since 2017, its status as a household name is relatively recent.

Insurance 104

Insurance Insurance Coverage FDA Documentation 104

STAT

DECEMBER 28, 2023

A slate of liver diseases got a rebrand this year. Experts hope the change can generate more conversation — and research interest — for conditions that still lack treatments.  A group of over 200 physicians, public health experts, industry representatives, regulatory officials, and patient advocates made the call in a supermajority vote: Non-alcoholic fatty liver disease, or NAFLD, would be renamed metabolic dysfunction-associated steatotic liver disease.

134

134

Drug Store News

DECEMBER 28, 2023

Available in three flavors—French Vanilla, Caramel Macchiato and Sweet & Creamy—the coffee shop-style foam comes with a topper that both creams and foams coffee.

105

105

Speaker: Chris Antypas and Josh Halladay

Access to limited distribution drugs and payer contracts are key to pharmacy expansion. But how do you prepare your operations to take the next step? Meaningful data: Collect and share clinical data regarding outcomes, utilization, and more Reporting: Limited distribution models require efficient tracking and reporting systems Workflows: Align workflows with specific pharma and payer contractual requirements For in-depth, expert insights on pharmacy expansion, watch this webinar from Inovalon.

STAT

DECEMBER 28, 2023

There’s an old story in journalism, and it goes like this: A reporter is asked, “What’s the best story you’ve ever written?” The reply? “The one I’m doing for tomorrow.” There’s a lot of that at STAT, and that’s why we’ve assembled an in-case-you-missed-it list of great stories from this year.

Hospitals 117

Hospitals 117

pharmaphorum

DECEMBER 28, 2023

Cytokinetics rises on report that its aficamten drug improved symptoms in people with rare disease obstructive hypertrophic cardiomyopathy

102

102

Pharmaceutical Technology

DECEMBER 28, 2023

J&J has acquired a global license for South Korean LegoChem’s ADC for $100m upfront along with milestone-based payments and tiered royalties.

98

98

STAT

DECEMBER 28, 2023

For most states, the new year means a new legislative session. STAT’s taking a look at some of the recent health policy trends that states will start to implement in 2024. As health care expenditures continue to grow nationally, states are especially interested in increasing how much oversight they have over health care costs — not just for their state Medicaid programs, but also for private insurance.

Insurance 112

Insurance Hospitals 112

European Pharmaceutical Review

DECEMBER 28, 2023

In this exclusive interview, Andreas Harstrick, the Chief Medical Officer of Affimed unveils the potential of innate cell engagers for treating lymphoma. As well as presenting recent findings from the pivotal AFM13-104 study, Andreas also reflects on the challenges encountered and conquered in developing Affimed’s innate cell engager, Acimtamig, which targets CD30 on lymphoma cells and CD16A on NK cells.

Immunization 84

Immunization Chemotherapy Medical Schools FDA 84

Drug Store News

DECEMBER 28, 2023

DSN spoke to Allen Warch, vice president, division merchandise manager at Dollar General, about its recent collaboration with Bayer.

92

92

Speaker: Dr. Ben Locwin - Biopharmaceutical Executive & Healthcare Futurist

What will the future hold for clinical research? A recent draft from the FDA provides valuable insight. In "Optimizing the Dosage of Human Prescription Drugs and Biological Products for the Treatment of Oncologic Diseases," the FDA notes that "targeted therapies demonstrate different dose-response relationships compared to cytotoxic chemotherapy, such that doses below the Maximum Tolerated Dose (MTD) may have similar efficacy to the MTD but with fewer toxicities.

FDA

Pharmaceutical Technology

DECEMBER 28, 2023

The MHRA gave Bristol Myers Squibb’s Opdualag marketing authorisation for advanced melanoma as part of Project Orbis.

98

98

pharmaphorum

DECEMBER 28, 2023

In this third instalment of the five-part, festive series of the pharmaphorum podcast, web editor Nicole Raleigh speaks with Mark Andrews, investment director of life sciences funds at British Patient Capital (BPC), discussing the vitally hot topic of investment in life sciences.

63

63

Pharmacy Times

DECEMBER 28, 2023

From newsworthy moments to groundbreaking research, these were the most listened-to podcasts on Pharmacy Focus in 2023.

73

73

pharmaphorum

DECEMBER 28, 2023

Medical billing errors have become a significant issue in the healthcare industry, causing financial losses for hospitals, insurers, and even patients. This article explores the impact of such errors in the United States, with a focus on coding and the need for improved systems and processes.

Insurance 63

Insurance Hospitals 63

Advertisement

Are you still using workarounds to manage your daily operations? To achieve peak performance, it's time to explore other options for specialty and infusion pharmacy software. Streamline pharmacy operations and improve clinical performance with automated processing, real-time data exchange, and electronic decision support. Download this helpful infographic to: Drive efficiency and patient adherence from referral receipt to delivery and ongoing care – all with our Pharmacy Cloud.

Pharmacy Management Software

Pharmacy Times

DECEMBER 28, 2023

From newsworthy moments to groundbreaking research, these were the most-read coronavirus-related articles on Pharmacy Times in 2023.

65

65

DiversifyRx

DECEMBER 28, 2023

Learn this simple pharmacy marketing trick to have more loyal patients. As an independent pharmacy owner, you may have realized that patients can’t always recognize the valuable difference between your pharmacy and the competition. As a pharmacy owner, it’s up to you to help them see the difference. You can share your awesomeness through your pharmacy marketing.

Independent Pharmacies 52

Independent Pharmacies 52

Pharmacy Times

DECEMBER 28, 2023

From newsworthy moments to groundbreaking research, these were the most watched videos on Pharmacy Focus in 2023.

65

65

pharmaphorum

DECEMBER 28, 2023

Get insights into FH23, the first Digital Medicine & DTx Global Policy Summit, where experts come together to discuss the latest advancements and policies in the digital health and DTx industry. Explore the intersection of technology, medicine, and policy in this global event.

52

52

Pharmaceutical Commerce

DECEMBER 28, 2023

Over the past year, Pharma Commerce’s digital coverage featured a variety of subject matters, ranging from how to calculate 340B prices, to the future of pharmacy.

52

52

Drug Store News

DECEMBER 28, 2023

The company said the One Flat Iron + Curler and Multi-Style Hair Dryer tools contain integrated technology to prevent heat damage.

52

52

Pharmaceutical Technology

DECEMBER 28, 2023

Elpiscience Biopharma has signed an agreement with Astellas Pharma for two new bispecific macrophage engagers for cancer.

52

52

BioPharm

DECEMBER 28, 2023

Tome Bioscience is facilitating the transition in biology from the editing phase to the cut-and-paste phase.

52

52

PharmExec

DECEMBER 28, 2023

As companies continued to expand their DE&I efforts, Pharm Exec was there to cover it in 2023.

52

52

BioPharm

DECEMBER 28, 2023

Is increasing molecular diversity pushing manufacturing ecosystem consolidation toward turnkey solutions?

52

52

Drug Store News

DECEMBER 28, 2023

Enhancements include the report now being organized by category for an easier-to-follow format.

52

52

DiversifyRx

DECEMBER 28, 2023

Patients can’t always recognize the valuable difference between your pharmacy and the competition. As an independent pharmacy owner, you may have realized that patients can’t always recognize the valuable difference between your pharmacy and the competition. As a pharmacy leader, it’s up to you to help them see the difference. One simple way to stand out is to use a fun monthly marketing trick I implemented decades ago, and that’s by decorating your pharmacy every single

Independent Pharmacies 52

Independent Pharmacies 52

STAT

DECEMBER 28, 2023

In recent months, evidence suggests, the war in  Ukraine  and the ongoing conflict in  Gaza have led to spikes of multidrug-resistant bacterial infections. This is to be expected; conflicts often create conditions that are perfect for drug resistance to emerge and spread, with the first evidence of this dating back as far as the 1940s.

143

143